Objectives: To determine the antibacterial activity of small cyclic plant proteins, i.e. cyclotides, and the importance of the surface exposed charged residues for activity.
Introduction
In recent years, there has been a marked decrease in the introduction of new antibacterial agents for clinical use. This is an alarming development, especially in light of the emergence of multidrug-resistant (MDR) bacteria, which is a challenge to the successful treatment of nosocomial as well as communityacquired bacterial infections. Some novel agents, for example quinupristin-dalfopristin and linezolid, have been introduced in response to the growing problem of resistance development in Gram-positive bacteria, but there are few new agents for the treatment of Gram-negative infections. 1, 2 In a review from 2009, it was found that no drugs against MDR Gram-negatives were in advanced stages of development and few leads were in pre-clinical trials. 3 The rapid development of antibiotic resistance in pathogenic bacteria has stimulated interest in the development of alternative pharmaceuticals that can complement or replace commonly used antibiotics. Antimicrobial peptides (AMPs) were discovered relatively recently, but they have become an intensive research field where much effort is focused on finding potential novel and future antibacterial drugs. AMPs can be found in all types of organisms, from bacteria themselves to humans, where they constitute a first line of defence as well as a part of the adaptive immune system. 4, 5 In this study, we focus on cyclotides, which are a large family of biologically active plant proteins with exceptional structural properties. 6 Cyclotides are 30 amino acids in length, have a circular backbone and three disulphide bridges arranged in a knotted manner: two disulphides and their connecting peptide backbone form an embedded ring through which the third disulphide penetrates (Figure 1) . 6, 7 The knot combined with the head-to-tail cyclic structure is referred to as the cyclic cystine knot motif, and accounts for the exceptional thermal, enzymatic and chemical stability of these proteins. 6, 8 The structural motif forces the hydrophobic parts of the protein to be exposed at the molecular surface. The hydrophobic residues form a patch on the surface, making the overall structure amphipathic. The hydrophobic patch is thought to have a major influence on the activity of the cyclotides.
Recent developments in chemical synthesis using solid phase and folding of the cyclotides into the correct 3D structure, including the problematic disulphide connectivity, enable the production of cyclotides that could otherwise only be isolated in small quantities or with non-native structure. 9 -11 In addition, chemical synthesis can be used to modify the cyclotide structure to determine the structure-activity relationship and also opens up the possibility of using cyclotides as a molecular scaffold for drug design.
Based on structural similarities, cyclotides are divided into two main subfamilies, referred to as the Mö bius and the bracelets based on the presence or absence of a cis-proline, respectively. 6 To date, the cyclotide family contains .100 sequenced peptides isolated from the Violaceae and Rubiaceae plant families, but many more await discovery. It has been estimated that the number of cyclotides in nature exceeds 10000. 12, 13 The high degree of stability and the structural diversity of the cyclotides, together with their wide range of reported biological activities, including anti-HIV, antifouling, antibacterial, insecticidal and cytotoxic effects, make them potential candidates for protein engineering in pharmaceutical and agricultural applications. 14 -19 The cyclotides are active in the lower micromolar range and in most assays they display steep dose-response curves with an on-off effect, i.e. only a small increase in concentration is required to move from no to full effect. Experimental data support a membrane-disrupting mechanism, but their exact mechanism of action, as well as the correlation between structure and potency, is still largely unknown. 20, 21 In this work, the antibacterial effect of cyclotides was determined against several bacterial species. The cyclotide with the most promising properties was the positively charged bracelet cyclotide cycloviolacin O2 (cyO2), which efficiently killed all Gram-negative bacterial strains tested, including important humans pathogens such as Pseudomonas aeruginosa and an MDR strain of Klebsiella pneumoniae. We further investigated the impact of the charged residues in cyO2 by removing the charges by chemical modifications. Masking of the single Glu or the two Lys residues resulted in a near total loss of activity against Salmonella enterica serovar Typhimurium LT2, whereas a derivate with the Arg modified retained low activity. The study provides further information about the activity of cyclotides and demonstrates the importance of charged residues for maintaining that activity.
Materials and methods

Extraction and isolation
CyO2 was isolated from dried aerial parts of Viola odorata L. (Violaceae), vaby A and D were isolated from Viola abyssinica Steud. ex Oliv. (Violaceae), and kalata B1 and B2 were isolated from Oldenlandia affinis D.C. (Rubiaceae). The cyclotides were extracted and isolated with minor modifications of a previously described method. 22 In short, 100 g of plant material was subjected to two subsequent extractions with 4 L of 60% aqueous methanol (MeOH). The extract was filtered and subjected to liquid-liquid extraction with dichloromethane (2:1). The aqueous phase was captured on reversed-phase (RP) material (C18), eluted with MeOH and then subjected to preparative RP-HPLC. Collected fractions were analysed using electrospray ionization mass spectrometry (ESI -MS) and further purified using RP-HPLC.
An Ä KTA basic HPLC system (Amersham Biosciences, Uppsala, Sweden) was used for all HPLC experiments, with detection at 215, 254 and 280 nm. A ReproSil-Pur C18-AQ column [250×20 mm internal diameter (i.d.), 10 mm, 300 Å ] was used for preparative HPLC, with a linear gradient from 10% acetonitrile in 0.05% trifluoroacetic acid (buffer A) to 60% acetonitrile in 0.045% trifluoroacetic acid (buffer B) over 45 min, operated at a flow rate of 5 mL/min. To purify native and modified proteins, an ACE C18 column (250×10 mm i.d., 5 mm, 300 Å ) was used with a linear gradient from 30% to 70% buffer B over 60 min, operated at a flow rate of 4 mL/min. The purity of the native peptides was determined by analytical RP-HPLC (Phenomenex C18, 250×4.6 mm i.d., 5 mm, 300 Å ) using a linear gradient from buffer A to B. All peptides were .95% pure. for the other peptides). The purified and freeze-dried peptides were dissolved in 10% DMSO (in water), except kalata B2, which was dissolved in 20% DMSO.
Sequence determination and quantification
Bacterial strains and media
Five Gram-negative and three Gram-positive bacterial strains were used in this study. The Gram-negative strains included S. enterica serovar Typhimurium LT2 (DA6192), Escherichia coli MG1655 (DA4201), P. aeruginosa (DA10176) and three K. pneumoniae strains (DA11895, DA11896 and DA15000). The Gram-positive strains tested were Staphylococcus aureus (DA7127), Staphylococcus epidermidis (DA10656) and Streptococcus pyogenes (DA7121). The bacterial strains are described in Table 1 . All dilutions were performed in PBS and cells were spread on Luria agar (LA) for viable counts.
Radial diffusion assay (RDA)
A modified version of the RDA described by Lehrer et al. 23 was used to evaluate the antibacterial activities of the examined peptides. In brief, bacteria were grown in trypticase soy broth (TSB, Becton Dickinson and Company, Sparks, USA) to an optical density at 600 nm of 0.3. One millilitre of culture was centrifuged at 3400×g for 10 min at 48C, and the bacteria were washed once and resuspended in cold sodium phosphate buffer (SPB, 10 mM, pH 7.4). Approximately 4×10 6 cfu were added to 10 mL of previously autoclaved (428C) SPB containing 0.03% w/v TSB, 1% w/v SeaKem LE agarose (Cambrex Bioscience Inc., Rockland, USA) and 0.02% v/v Tween 20 (Sigma-Aldrich, St Louis, USA). The mixture was vortexed and poured into a Petri dish (diameter 85 mm). Evenly distributed wells were made using a 3 mm gel punch and 5 mL of peptide sample (concentration 250, 62.5 and 31.3 mM) or control (5 mL 10% DMSO) was added to each well. The cathelicidin peptide LL-37 was used at the same concentrations as a positive control. The agarose plates were incubated for 3 h at 378C to allow diffusion of the peptides, after which the surface was covered with 10 mL of overlay gel solution (428C) consisting of 6% w/v TSB and 1% w/v agarose in 10 mM SPB. After 18 -24 h of incubation, the diameter of the clear zone around the wells was measured.
MIC assay
MIC assays were performed in 10 mM SPB supplemented with 0.1% TSB in 96-microwell plates (round bottom; Nunc A/S, Roskilde, Denmark). Bacteria were grown overnight (10 mM SPB/0.1% TSB) and diluted to 5×10 5 cfu/mL. Then, 90 mL of bacterial solution was mixed with 10 mL of peptide solution of different concentrations (the highest concentration of each peptide was: cyO2, 50 mM; kalata B1, 100 mM; kalata B2, 35 mM; vaby A, 90 mM; and vaby D, 90 mM). The microwell plates were incubated with continuous shaking at 378C. The assay medium allowed sufficient growth of S. enterica serovar Typhimurium LT2 and E. coli to visually determine the MIC of the different peptides. For S. aureus, the viable count in the different peptide concentrations after treatment was determined and compared with viable counts in control wells without peptide. Experiments were performed with duplicates of each sample on at least two separate occasions and the average MIC was calculated.
Time -kill kinetics
For strains DA6192, DA10656, DA11895 and DA11896, bacteria were grown to OD 600 0.2 in Mueller-Hinton broth (Becton Dickinson and Company, Sparks, USA), washed once and resuspended in cold 10 mM SPB containing 0.03% TSB. The bacteria were diluted 1:10 in SPB/0.03% TSB and then 80 mL of the diluted bacteria was mixed with various concentrations of cyO2 or a control solution (10% DMSO) to a final volume of 100 mL. The tubes were incubated at 378C in a shaking incubator. Ten microlitre samples (resulting in a minimum detection limit of 100 cfu/ mL) were removed, diluted and spread on LA before the addition of cyO2 and at 1, 3, 5 and 24 h after cyO2 supplementation. For some strains, the viable count after 20 min was determined. In later experiments with strains DA4201, DA7127, DA10176 and DA15000, bacteria were grown overnight in SPB supplemented with 0.1% TSB [S. pyogenes (DA7121) did not grow in this medium, and colonies were therefore picked from blood agar and resuspended in SPB/0.1% TSB] and subsequently diluted to 5×10 6 cfu/mL in SPB/0.03% TSB. From this dilution, 90 mL was added to each assay tube containing 10 mL of peptide solution. Sampling was performed in the same way as described above. With this method, the bacteria were killed to the same extent as when using log-phase bacteria, although slightly slower. All bacterial strains 
Chemical modifications
The Glu residue of cyO2 was esterified by slowly adding 1.0 mL of acetyl chloride to 6.0 mL of dry MeOH. 24 The mixture was stirred at room temperature for 5 min and then added to 3.0 mg of cyO2. The reaction was carried out at room temperature for 1 h and then quenched by adding 13 mL of water. For acetylation of the two Lys residues, 1.8 mg of cyO2 was dissolved in 3 mL of 50 mM NH 4 HCO 3 and mixed with 30 mL of acetic acid anhydride in 450 mL of dry MeOH. 25 The reaction was carried out at room temperature for 2 min and subsequently diluted with 6.0 mL of water. To modify the Arg residue, 47 mg of 1,2-cyclohexanedione (CHD) was dissolved in 5 mL of 0.2 M H 3 BO 3 containing 1 M NaCl (pH 8.5) and added to 1.5 mg of cyO2. 26 The mixture was allowed to react for 18 h at 378C under an N 2 atmosphere. The reaction was stopped by the addition of 3 mL of 30% acetic acid. CyO2 derivatives were purified by RP-HPLC immediately following reactions.
The molecular weight of the products increased as expected: +14 Da for [Glu(Me)]cyO2; +84 Da for [Lys(Ac)] 2 cyO2; and +113 Da for [Arg(CHD)]cyO2. The exact positions of the cyO2 modifications were confirmed with MS/MS analysis after reduction, S-carbamidomethylation and cleavage, as described above. The purity of the modified peptides was determined by analytical RP-HPLC, as described for the native peptides above. All peptides were .95% pure. The peptides were weighed (.2 mg) or quantified by UV absorption at 280 nm using the calculated molar absorption coefficient of cyO2 at 280 nm.
The activity of the chemically modified cyO2 derivatives was determined against S. enterica serovar Typhimurium LT2 (DA6192) in timekill assays, as described above.
Results
RDA and MIC assay
Previous studies have shown that the RDA is a useful method to detect antimicrobial activities of different substances. 23, 27 Therefore, this method was used in the initial screen for antibacterial activities of the bracelet cyclotide cyO2, and the Mö bius cyclotides kalata B1, kalata B2, vaby A and vaby D. Activity against two bacterial strains, S. enterica serovar Typhimurium LT2 and S. aureus, was evaluated and the resulting zone sizes can be found in Table 2 . CyO2 at concentrations of 62.5 and 31.3 mM inhibited the growth of S. enterica serovar Typhimurium LT2, resulting in zone sizes of 7 and 6 mm, respectively, while the well-characterized and potent AMP LL-37 at the same concentrations formed zones of 3 and 2 mm, respectively. For vaby A and D, smaller zones were formed in the bacterial lawns upon treatment with a high concentration of peptides (250 mM), suggesting that these peptides are less active. Kalata B1 and B2 did have an effect on the examined bacteria, but inhibition was not complete (the zones were not completely clear). In contrast, S. aureus was not inhibited by any of the cyclotides tested, i.e. no zones were formed in the bacterial lawn. An RDA was also performed with E. coli (data not shown). Results from that assay indicated that E. coli is more susceptible to all the tested cyclotides than S. aureus and S. enterica serovar Typhimurium LT2, although cyO2 was still the most potent peptide. However, E. coli did not grow as well as the other two strains in the assay media, and the results could therefore not be directly compared between the strains and are not included here.
A disadvantage with the RDA is the difficulty in interpreting the potency of the peptides, e.g. the peptides may diffuse differently in the media. It is also difficult to estimate how many cells have actually been killed/inhibited. To confirm and expand the results from the RDA, the MIC of each cyclotide against S. enterica serovar Typhimurium LT2, E. coli and S. aureus was determined in a microdilution assay. The resulting MICs are presented in Table 3 . In accordance with the RDA results, cyO2 was the most active cyclotide, with an MIC of 9 and 2 mM against S. enterica serovar Typhimurium LT2 and E. coli, respectively. For Salmonella, the MIC of vaby A was 90 mM, while kalata B1, kalata B2 and vaby D had no inhibitory activity at the concentrations tested. E. coli was more susceptible, particularly to the vaby peptides, which had an inhibitory effect at 30-50 mM. Kalata B1 at the highest concentration tested (100 mM) was enough to inhibit the growth of E. coli in some of the experiments. The Gram-positive S. aureus grew as well in cyclotide-supplemented media as without, except at the highest concentration of kalata B2 (35 mM), for which the number of viable cells had decreased to 40% of the inoculum after 24 h of incubation. From these Antibacterial properties of cyclotides 1967 JAC initial screens, cyO2 was singled out as the most potent antibacterial cyclotide and was subjected to further testing.
CyO2 time -kill kinetics
To further define the activity spectra of cyO2, several bacterial strains were subjected to the cyclotide and bacterial viability was monitored over time. The resulting killing curves can be seen in Figure 2 , where bacterial survival is given as a percentage of the starting inocula. CyO2 at 25 and 12.
5 mM efficiently killed all tested Gram-negative species, including an MDR strain of K. pneumoniae. To determine the lowest concentration at which cyO2 was still effective, E. coli and P. aeruginosa were subjected to lower concentrations of the peptide (6, 3 and 1 mM). E. coli was the more susceptible of the two strains, and was killed by both 6 and 3 mM peptide, while 1 mM only caused a slight reduction in the number of viable cells. P. aeruginosa was somewhat less susceptible and survived, although affected, treatment with 3 mM cyO2. A few cells survived treatment with 6 mM cyO2. DA11896, a capsule-mutated variant of K. pneumoniae strain DA11895, was as susceptible as the parental, capsuleproducing strain (data not shown). Amongst the Gram-positives, S. aureus was resistant to cyO2 (the number of viable cells after 24 h treatment with cyO2 was only slightly reduced compared with the control), in accordance with what was observed in RDAs and MIC assays, as was S. epidermidis. On the other hand, S. pyogenes was more susceptible to cyO2 and all cells were killed within 5 h of treatment. However, this strain was for unknown reasons sensitive to the assay media and the cells were killed also in control experiments without cyO2, although at a slower rate, making it difficult to quantitatively assess the potency of cyO2 against this strain.
Antibacterial activity of chemically modified cyO2
Methylation of the sole glutamic acid residue in cyO2 has been found to reduce the cytotoxic activity of the peptide 48-fold, while masking of the positively charged arginine or the two lysines produced no effect or a 3-fold loss in activity, respectively. 22 To determine the importance of these residues for the antibacterial activity of cyO2, we subjected S. enterica serovar Typhimurium LT2 to each of these three modified peptides Pränting et al.
compared their activity with that of the original peptide. As can be seen in Figure 3 , masking of the glutamic acid or the two lysines caused a near total loss of activity against S. enterica serovar Typhimurium LT2 at both 12.5 and 25 mM peptide. Modification of the arginine also resulted in reduced activity, but 25 mM peptide still killed the bacteria, although at a slower rate than the parental cyO2.
Discussion
Cyclotides are miniproteins from plants that possess several characteristics that are advantageous from a drug development point of view. They contain a versatile protein scaffold that is capable of carrying highly diverse sequences in the loops between cysteines, and that is exceptionally resistant to heat and chemical degradation. 8 In addition, cyclotides are stable against proteases such as trypsin, pepsin, thermolysin and endoprotease Glu-C, and their cyclic structure protects against exopeptidases. 8, 28 As such, the use of cyclotides and the cyclic cystine knot motif in drug design could potentially circumvent many of the general limitations of using peptides as drugs, such as sensitivity to proteolytic degradation. 4, 29 Importantly, cyclotides have also been proved to be able to carry a multitude of biological activities: new activities have been engineered into the cyclotide framework, but native cyclotides, as isolated from the plants, have also shown significant activities in a series of biological systems. 14 -17,29,30 In the current study, we have examined the activity of cyclotides against bacteria. Of the five peptides examined (cyO2, kalata B1, kalata B2, vaby A and vaby D), cyO2 was by far the most potent. Although kalata B2 had some activity against S. aureus, and vaby A and D at concentrations of 30-50 mM inhibited the growth of E. coli, their potency was much lower than that observed for cyO2, and these peptides were therefore not studied further.
In time -kill assays, cyO2 killed all tested Gram-negative bacteria, while the Gram-positives were more resistant to treatment. The antibacterial effect of cyO2 was influenced by the composition of the media, with lower activity observed in rich media or media containing salt (data not shown). Similar effects of media components were seen in a study by Tam et al. 18 and are also a common feature among other types of AMPs, which nevertheless are active against bacteria in biological systems. 5, 27, 31, 32 It should be noted that S. enterica serovar Typhimurium LT2 was the least susceptible of the Gram-negative strains examined. Several of these strains are known to have genetic pathways that can be up-regulated to produce a less negatively charged outer membrane. 33, 34 This, in turn, increases the resistance to positively charged peptides, since the electrostatic attraction to the bacterial membrane decreases. A possible explanation for the differences in susceptibility between the Gram-negative strains may be their ability to modify their membrane charges in the assay media. That S. enterica serovar Typhimurium LT2 is the least susceptible strain may reflect a more efficient up-regulation of such defence mechanisms. One example of a resistance pathway is the PhoP -PhoQ two-component system, which is regulated by extracellular Mg 2+ concentrations. 33 Among other things, activation of this system leads to induction of the PmrA-PmrB signalling system, which, in turn, activates a pathway responsible for incorporating 4-aminoarabinose into lipopolysaccharides, generating a less negatively charged membrane. Our experiments were performed at a low Mg 2+ concentration, a condition that should activate the PhoP -PhoQ system and, thus, peptide resistance mechanisms in the bacteria. A Salmonella pmrB mutant, which is thought to have the 4-aminoarabinose pathway up-regulated independently of PhoP -PhoQ, was as susceptible to cyO2 as the wild-type strain (data not shown), indicating that these systems are already expressed in the wild-type background due to the low magnesium content of the media. 35 Interestingly, there was no significant difference in susceptibility between a capsule-producing and a capsule-deficient strain of Klebsiella, although other studies have demonstrated an increased susceptibility to AMPs in capsule-deficient strains. 36 Llobet et al. 37 showed that shed anionic capsule polysaccharides can be used as a decoy against AMPs and inhibit their antibacterial effect, although they also found that the efficiency of decoying varies depending on the peptide. It is possible that cyO2 does not interact with shed polysaccharides and efficiently penetrates the capsule, explaining why we see no effect of the capsule. Alternatively, the capsule-producing strain may not produce enough capsule in our assay medium (10 mM SPB/0.03% TSB) to avoid the killing effects of cyO2 at the concentrations tested. 
JAC
Masking of the charged residues in cyO2 had a profound effect on activity. The diminished activity observed when masking the positive charges (i.e. the two Lys or the Arg residue) may be explained by the suggested mechanism of action of cyO2, namely disruption of the cell membrane. 20 The initial contact between AMPs and the bacteria is generally believed to occur through electrostatic attraction between the cell membrane or cell wall and the peptides. 4 Accordingly, masking of the positive charges in cyO2 (which has a net charge of +2) may result in a decreased attraction to the bacterial membrane. The positive charges seem to be more important for interaction with bacteria than cancer cells, since Arg-modified cyO2 has been shown to be equally potent as cyO2 against human lymphoma cell lines. 22 The positive charges have also been demonstrated to be important for e.g. anthelmintic activity of cyO2. 30 According to the hypothesis above, masking of the Glu residue should lead to a higher activity through stronger interaction with the bacterial membrane, since a negative charge has been removed, making the overall charge of the peptide more positive. This was, however, not the case: masking of Glu resulted in a near total loss of activity. This observation is likely explained by distortion of the intramolecular rather than the intermolecular structure interactions. The Glu residue is conserved among cyclotides and has been found in almost all cyclotides isolated to date. 38 It also seems to be important for activity, independent of whether that activity induces leakage across model membranes, or is cytotoxic, anthelmintic or antibacterial, as seen in the current study. 21, 22, 30 In bracelet cyclotides such as cyO2, the glutamic acid has a key structural role in coordinating a set of hydrogen bonds to the a-helical and hydrophobic loop 3 (see Figure 1) , and this interaction is disrupted in the methylated analogue. 39 Furthermore, the glutamic acid is hypothesized to stabilize the cyclotide structure, to allow efficient aggregation in membranes. Without the stabilizing hydrogen bond network, the membrane interactive hydrophobic patch becomes disordered, which indirectly leads to a decreased interaction with the target membrane and, thus, a decrease in activity.
The antibacterial properties of cyclotides have been addressed in two previous studies, although with contradictory results. In the study by Tam et al. 18 , four cyclotides were targeted by total chemical synthesis and subsequently examined for activity against different bacteria (four Gram-negatives and two Gram-positives) using RDA. Synthetic cyclotides, including kalata B1 in particular, were found to be active against the Grampositive S. aureus at sub-micromolar concentrations, but relatively ineffective against Gram-negatives. In contrast to those results, Gran et al. 40 found native kalata B1 to be inactive against S. aureus, but active against a Gram-negative strain [E. coli, although only a high (millimolar) peptide concentration was tested], which is congruent with the results in the current study. It is possible that the chemically synthesized cyclotides examined by Tam et al. possess different activity than cyclotides isolated directly from the plant, e.g. because of differences in the structural fold or connectivity of disulphide bonds. Other possible explanations are differences in susceptibility between the S. aureus strains used or in the experimental conditions used. The results of the current study, however, unambiguously demonstrate that cyclotides (i.e. cyO2) possess potent antibacterial activity in a concentration-and time-dependent manner, which mainly targets Gram-negative species.
These results indicate that cyclotides could have a biological role in protection against bacterial infections. This is, maybe, not surprising, because cyclotides disrupt cell and lipid membranes (which also has been suggested as the general mechanism of action for other biological effects of cyclotides), and because membrane disruption is thought to be the main mechanism of action of many AMPs from different organisms. 4,19 -21 Cyclotides are native to many plants, where they may play a role in the defence against plant pathogenic bacteria. This role may be extendable to their use as antibacterial drugs in humans. Indeed, cyclotides tested in the current study display structure-activity relationships when assayed against clinically relevant pathogens and specificity between target organisms. Together with the recent advances in the chemical synthesis and oxidative folding of cyclotides, these results demonstrate that the structurally unique cyclotide scaffold is a potential starting point for the design of peptide antibiotics. 9 -11 
